SCNI Earnings Scinai Immunotherapeutics Ltd.
Reported EPS, revenue and net income by fiscal period (SEC EDGAR) — quarterly and annual. Full financials → Chart & overview → Updated
Annual results
EPS
Revenue
Net income
Quarterly results
EPS
Net income
ROE
Reported EPS history
1–4 of 4
| Q1 2023 | 2023-03-31 | -0.00 | 2023-05-15 | 10-Q |
| FY 2022 | 2022-12-31 | -0.01 | 2023-04-17 | 10-K |
| Q1 2023 | 2022-03-31 | -0.00 | 2023-05-15 | 10-Q |
| FY 2022 | 2021-12-31 | -0.02 | 2023-04-17 | 10-K |
Source: SEC EDGAR / XBRL (reported actuals; no consensus estimates). Some issuers (e.g. mortgage REITs, banks) don't report a conventional revenue line, so those charts may be omitted. Informational only — not financial advice.